🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 81577F109 (prev. 03832V307 )
- Market Cap
- Small Cap
- Previous Symbol
- APRI (changed 1/24/2019)
- Previous Name
- Apricus Biosciences, Inc.
Business: Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company's portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases.
Notes: January 24, 2019, Seelos Therapeutics, Inc. (Nasdaq: SEEL) announced the completion of its previously disclosed merger with Apricus Biosciences, Inc. The combined company changed its name to Seelos Therapeutics, Inc. October 24, 2016 - Apricus Biosciences, Inc. (APRI) will effect a of its common stock. The CUSIP number will change to 03832V307.
Company Contact
- CEO
- Raj Mehra
- CFO
- Michael Golembiewski
- Headquarters
- 300 Park Avenue, 12th Floor, New York, NY 10022
- Phone
- 646-293-2100
- Fax
- 858-436-8155
- Investor Relations
- Anthony Marciano · 858-222-8041 · anthony.marciano@seelostx.com